Categoría: Geovanny Vicente

DUBLIN, Aug. 4, 2020 /PRNewswire/ — The «Canada Wind Power Market Outlook to 2025» report has been added to ResearchAndMarkets.com’s offering.

Even as the wind power generation technology is now relatively advanced, the industry is reaching a stage of maturity in the key markets with some other markets still evolving.

In 2019, around 60.4 GW of new wind power capacity was added globally, making it the second-largest year in history and close to the largest year in 2015 (63.8 GW), bringing global cumulative wind power capacity up to 651 GW. The massive wind turbine installation were primarily the result of a strong year in both China and the US: the world’s two largest markets ahead of the expiry of Feed-in Tariffs (FiT) for onshore in the first country and the PTC (extended until the end of 2020 in Dec 2019) in the second.

This report provides comprehensive market analysis on the historical development and targets, the current state of wind power installation scenario, and its outlook. The insights in the research report: market data, policies and regulations, project data, company profiles, and competitive landscape analysis – have been derived primarily from our proprietary databases, and offerings.

The report discusses the impact of the ongoing COVID-19 pandemic on the wind power market, economic trends, and investment and financing scenario in Canada. It gives insights into the market dynamics and the challenges of wind power development in the country. It also comprises significant market development trends and highlights how the socio-economic, environmental, and political factors affect the nation’s wind market.

Key Topics Covered

1. Executive Summary

2. Research Scope and Methodology

3. Market Analysis
3.1 Introduction
3.2 Market Dynamics
3.2.1. Drivers
3.2.2 Restraints
3.3 Market Trends & Developments
3.4 Analysis of COVID-19 Impact
3.5 Market Opportunities
3.6 Key Projects
3.7 Government Policies and Regulations

4. Market Outlook
4.1 Annual Wind Power Installed Capacity, 2001-2025, in GW
4.2 Cumulative Wind Power Installed Capacity Forecast, 2001-2025, in GW

5. Business Activity Analysis
5.1 Supply Chain Analysis
5.2 PESTLE Analysis

6. Competitive Landscape
6.1 List of Notable Players in the Market
6.2 M&A, JV, and Agreements
6.3 Strategies of Key Players

7. Key Company Profiles

8. Conclusions and Recommendations

Companies Mentioned

• GE Renewable Energy (General Electric Company)
• Vestas Wind Systems A/S
• Siemens Gamesa Renewable Energy (SGRE)
• Nordex Group
• Enercon GmbH
• Xinjiang Goldwind Science & Technology Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/6e2o3q

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/canadian-wind-power-industry-outlook-2020-2025-and-competitive-landscape-analysis-301105583.html

SOURCE Research and Markets

WASHINGTON, Aug. 4, 2020 /PRNewswire/ — The Medicare Physician Fee Schedule proposed rule released by the Centers for Medicare & Medicaid Services (CMS) for calendar year 2021 (CY2021) jeopardizes patient care, specifically surgical care. While the proposed rule takes steps to increase access to care through telehealth, it also has the potential to drastically reduce patients’ access to surgical care, just as many patients have delayed care due to COVD-19.

In the fee schedule announced by CMS, surgeons will see their Medicare payments cut by 9% for cardiac surgery, 8% for thoracic surgery, 7% for vascular surgery, 7% for general surgery, 7% for neurosurgery and 6% for ophthalmology for CY2021.

«We support steps to expand access to care, but this rule takes one step forward and several steps back by disregarding patients’ needs and the surgeons who care for them. The middle of a pandemic is no time for cuts to any form of health care, yet this proposed rule moves ahead as if nothing has changed. The health care system cannot absorb cuts of this magnitude,» said David B. Hoyt, MD, FACS, American College of Surgeons Executive Director. «The Surgical Care Coalition believes no physician should see payment cuts that will reduce patients’ access to care. This proposed rule would move forward with significant payment cuts that will only make the situation worse and harm patients.»

The proposed rule affirms, and for some surgical specialties increases, the cuts CMS announced last year, which are set to take effect January 1, 2021. These cuts will reduce payments to nearly all surgical specialties, including by as much as 9 percent for some surgeons. The policy was ill-informed and dangerous to patients even before the pandemic started but could be even more detrimental as our health care system continues to weaken under COVID-19.

To stop these cuts and preserve care for patients, Congress must act now. The Surgical Care Coalition is urging Congress to enact legislation to waive Medicare’s budget neutrality requirements for these E/M adjustments and to require CMS to apply the increased E/M adjustment to all 10- and 90-day global code values.

In a survey earlier this year, one-in-three private surgical practices stated that they are already at risk of closing permanently due to the financial strain of the COVID-19 crisis. In the same survey, it was found that nearly half of surgeons face more difficult financial decisions, and are responding by either cutting their own pay or paying employees in the face of declining revenues. This rule will likely force surgeons to take fewer Medicare patients leading to longer wait times and reduced access to care for older Americans.

About the Surgical Care Coalition
The Surgical Care Coalition advocates for access to quality surgical care for all Americans. The Surgical Care Coalition is comprised of 12 surgical professional associations that proudly represent more than 150,000 surgeons working across the country with a common goal of improving the quality of care, and quality of life, for all patients. The founding members have worked together for nearly three decades to promote sound policy solutions to the U.S. Congress and federal regulatory agencies to solve the biggest challenges in health care.

Contact
media@surgicalcare.org   

View original content to download multimedia:http://www.prnewswire.com/news-releases/proposed-medicare-physician-fee-schedule-rule-jeopardizes-patient-care-argues-the-surgical-care-coalition-301105744.html

SOURCE Surgical Care Coalition

DALLAS, Aug. 4, 2020 /PRNewswire/ — Family-owned Dallas based metal fabrication shop, the NoContactKey has risen in popularity since the introduction of their one of a kind clean touch key. The NoContactKey is a no contact door opener, tool and stylus made of metal antimicrobial brass. To help parents and students heading back to school in-person feel more comfortable as they navigate a challenging learning environment during this pandemic, NoContactKey has expanded their product selection to include a child size version of their clean touch germ key, perfectly suited for children’s fingers.

Currently, the NoContactKey is the number one hygiene tool supplying clients throughout the country with their no touch hand tools. The demand from consumers for additional PPE so that they may feel safe handling daily tasks has resulted in NoContactKey’s shop processing thousands of orders a day and becoming a large-scale production allowing them to pivot quickly to better serve teachers, students and schools.

«Every parent wants to be assured that the school their children will attend this fall is taking serious precautions against the spread of COVID-19,» said Don Douglas, founder of NoContactKey. «Despite schools’ major efforts towards cleanliness and social distancing, community spread of the virus is still a prevalent reality. That is why we feel every child and teacher should have their own NoContact Key as an extra precaution to reduce the number of germy shared surfaces they are exposed to throughout the day.»

https://www.nocontactkey.com/product/nocontactkey-for-kids/

Parents, teachers and students can feel safer and stay healthier by explaining to the kids how to use the NoContactKey and reinforcing the importance of trying to avoid directly touching shared surfaces.

• With the help of a no contact germ tool like the NoContactKey, your children can enter a school without worrying about touching door knobs or pressing buttons.
• A child can use the brass door opener keychain hook and the weight of a door is not a factor but rather the amount of resistance the door closer provides. The door closer is the device mounted at the top of the door and is responsible for controlling how much effort is required to open the door. If a door closer resistance is adjusted to the ADA standard of 5 pounds or less, then the user will be able to easily open the door using the NoContactKey.
• Keeping a NoContactKey easily accessible allows your children to avoid using their hands to press water fountain buttons, touch school locker handles, push elevator buttons, lower toilet handles, etc.
• The NoContactKey also serves as a high-quality stylus which can be used on many touch screen learning devices including iPad tablets.

The NoContactKey germ utility tool can be the added assurance parents need for their children to head back to school safely. When it comes to procuring PPE for the coming year, Parent Teacher Associations and school administrators can provide additional peace of mind to families and staff by providing the best no touch tool made from antimicrobial brass. by not touching shared surfaces. Made from antimicrobial brass, it is the best no touch tool available!

For more information about the NoContactKey and its functions, visit www.nocontactkey.com

Contact:
Don Douglas
2012202066
244699@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/no-touch-door-opener-tool-helps-keep-kids-germ-free-301105740.html

SOURCE NoContactKey.com

LOS ANGELES, Aug. 4, 2020 /PRNewswire/ — The Michelson Medical Research Foundation and the Human Vaccines Project have announced the winners of the 2020 Michelson Prizes for Human Immunology and Vaccine Research. The awards support the research of two early-career investigators who are advancing human immunology, vaccine discovery, and immunotherapy across major global diseases.

This year’s recipients are Danika Hill, Research Fellow at Monash University, and Michael Birnbaum, Assistant Professor at MIT. They will each receive unrestricted grants of $150,000.

2020 will be remembered as the year the world endured an unprecedented public health crisis with vast implications for the entire global community. The COVID-19 pandemic highlights the critical need for unorthodox research in immunology and vaccine discovery. Daring young pathfinders need partnerships with those who believe in their potential. That is why the Michelson Medical Research Foundation and the Human Vaccines Project engage in an annual international search to identify and support the most promising projects from young investigators.

«Our current system is rigged, making it nearly impossible for a young researcher to get funding,» says Dr. Gary Michelson, founder, and co-chair of the Michelson Medical Research Foundation. «Even the head of the NIH cites the advancing age at which investigators receive their first NIH grant as ‘the greatest problem facing U.S. science.’ History shows that profound breakthroughs are made by researchers under age 35. We must invest in next-generation scientists who have demonstrated excellence in their field by combining disruptive thinking with a novel scientific approach. My wife Alya and I are proud to help Dr. Hill and Dr. Birnbaum pursue their revolutionary ideas.»

«We need courage, passion, and creativity to achieve true progress in science. It inspires me to see young researchers like Dr. Hill and Dr. Birnbaum display these strengths with their innovative proposals,» says Dr. Wayne Koff, CEO of the Human Vaccine Project. «Only by thinking beyond conventions, we will be able to transform the future of human health. I look forward to seeing how the research of our 2020 Michelson Prize winners will contribute to the Human Vaccine Project’s grand vision of decoding the human immune system.»

About the winners:

Danika Hill, Research Fellow, Department of Immunology and Pathology, Monash University, Melbourne, Australia.

Danika Hill received the Michelson Prize 2020 for: «Exploiting T Follicular Helper Cells as an Innovative Tool to Discover Targets for Long-Lived Humoral Immunity.»

Dr. Hill aims to find specific antigens responsible for long-lived humoral immunity. With the help of a human Strep A challenge model, she will identify T cell receptor types in circulating T Follicular helper cells, which will be used to engineer reporter cell lines to uncover novel vaccine candidates. Dr. Hill uses an innovative approach with clear trans-disease applicability to identify antigens for vaccines or immunotherapy for various infectious diseases, cancer, and autoimmunity.

«The Michelson Prize comes at a critical point in my career,» says Dr. Hill. «It will enable me to peruse my own research directions and enable me to follow-up on some exciting discoveries that I’ve made. With the prize, I’ll be able to apply some cutting-edge techniques to study hundreds of thousands of cells in molecular detail. And it’s my hope that with this project we can better understand what to pinpoint when we design vaccines to generate these T follicular helper cells that are so essential for good vaccine responses.»

Michael Birnbaum, Assistant Professor, Department of Biological Engineering, MIT, Cambridge, Mass.

Michael Birnbaum received the Michelson Prize 2020 for: «Repertoire-Scale Determination of T Cell Recognition and Cross-Reactivity to HIV via pMHC Lentiviral Display»

Dr. Birnbaum strives to expedite and perfect the process of vaccine antigen selection. He is using HIV «elite controllers,» who can safely go long periods without treatment, to identify which antigens their immune system successfully targets. By working with a lentiviral display, he can identify specific antigens, which might be ideal targets for use in HIV vaccines. Dr. Birnbaum’s method is applied for HIV but can easily be expanded to various other diseases, including infectious diseases, cancer, and autoimmunity.

«The Michelson Prize is funding our development and deployment of a technology that would supercharge our ability to define what T cells recognize during the course of HIV infection. The support provided by this award will let us work faster than would be possible otherwise. We will be trying many of our best ideas at once to press this technology into service, in a time where better tools to study infectious disease are clearly needed,» Dr. Birnbaum explains.

The Michelson Prize 2020 winners were selected from more than two hundred applicants from around the world. Hill and Birnbaum will receive their awards in an open webinar on August 13, 2020, at 9 a.m. EDT. This special two-hour event connects the experts of today with the leaders of tomorrow: Pulitzer Prize winner Laurie Garrett will introduce the winners and preside over the presentation of awards. After the award presentation, Harvard Professor Dr. Dan Barouch will present the latest data set published in Nature with his insights on the pandemic in the Global COVID Lab Meeting, where the Human Vaccines Project connects experts in the field to discuss the latest COVID-19 data. Everybody is welcome to join the event. Register for the webinar here.

About the Michelson Medical Research Foundation
Founded by Dr. Gary K. Michelson in 1995, the Michelson Medical Research Foundation accelerates solutions to global health challenges by fostering high-risk, high-reward approaches that disrupt the status quo to make innovative ideas a reality. Through convergent collaboration among engineers, scientists, and physicians, the foundation helps rapidly move bold concepts and technologies from the laboratory into clinics and communities around the world. For more information, visit https://www.michelsonmedicalresearch.org/ 

About the Human Vaccines Project
The Human Vaccines Project is a bold public-private initiative that aims to decode the human immune system to make the next leap forward in human health. Pioneering a new era in health, the Human Vaccines Project will enable the creation of next-generation vaccines, diagnostics, and therapies across diseases. For more information, visit https://www.humanvaccinesproject.org/ 

View original content to download multimedia:http://www.prnewswire.com/news-releases/mit-monash-university-researchers-awarded-150-000-michelson-prizes-for-human-immunotherapy-and-vaccine-research-301105012.html

SOURCE Michelson Medical Research Foundation